Prior Authorization: Major Burden for 7 in 10 Insured Adults – KFF Poll

by Chief Editor

Prior Authorization: The Growing Headache for American Healthcare Consumers

Affordability remains the top concern for Americans when it comes to healthcare, but a new KFF Health Tracking Poll reveals a different, equally frustrating problem: prior authorization. This process – requiring insurance approval before accessing certain tests, treatments, or medications – is increasingly seen as a major burden, impacting nearly 70% of insured adults.

What is Prior Authorization and Why is it a Problem?

Prior authorization isn’t a new concept, but its prevalence is growing. Insurance companies use it to control costs, but the process often creates significant hurdles for patients and providers. It can lead to delays in care, denials of necessary treatments, and increased administrative burdens for everyone involved.

The KFF poll found that one in three insured adults consider prior authorizations a “major burden,” with an additional 37% viewing it as a “minor burden.” This surpasses the burden reported from understanding medical bills (60%), scheduling appointments (60%), or finding in-network providers (53%).

Chronic Conditions Amplify the Issue

The impact of prior authorization is particularly acute for individuals managing chronic conditions. Nearly 40% of insured adults with chronic illnesses identify prior authorizations as their single biggest healthcare burden, more than double the rate of other concerns. This is because those with ongoing medical needs often require more frequent treatments and medications, leading to more interactions with insurance companies.

Delays and Denials: Real-World Consequences

The consequences of prior authorization extend beyond mere inconvenience. Approximately two-thirds of adults report that delays and denials of healthcare services by insurance companies are a “major problem.” Around 33% have experienced a denial of coverage, 29% have faced delays in receiving care, and 29% have been required to try a less expensive alternative before their preferred treatment was approved.

These delays and denials aren’t just frustrating; they can have tangible negative impacts. One-third of those affected report a major negative impact on their mental health and finances, while one in four experienced a negative impact on their physical health.

A Bipartisan Concern

Interestingly, the frustration with prior authorization transcends political divides. The KFF poll shows that it’s a significant burden across party lines, as well as among individuals with different types of insurance, including Medicaid, employer-sponsored plans, and those who purchase insurance directly.

Looking Ahead: Potential Trends and Solutions

Several trends suggest the prior authorization issue will likely intensify in the coming years. Healthcare costs continue to rise, putting pressure on insurers to find ways to control spending. The increasing complexity of medical treatments and the growing number of individuals with chronic conditions will too contribute to the problem.

However, there’s also growing momentum for solutions. Legislative efforts are underway in several states to streamline the prior authorization process and increase transparency. Some insurers are experimenting with “gold carding” programs, which exempt providers with consistently high approval rates from prior authorization requirements for certain services. Technology solutions, such as automated prior authorization tools, are also emerging.

The Rise of Automation

Artificial intelligence (AI) and machine learning are poised to play a larger role in automating the prior authorization process. These technologies can analyze medical records and clinical guidelines to determine whether a treatment is likely to be approved, potentially reducing the need for manual review. However, ethical considerations and the need for human oversight will be crucial.

Increased Transparency

Greater transparency from insurance companies is another key area for improvement. Patients and providers need clear information about prior authorization requirements, approval rates, and the reasons for denials. Standardized forms and electronic submission processes can also help streamline the process.

FAQ

Q: What is the purpose of prior authorization?
A: Insurance companies use prior authorization to manage costs and ensure that medical treatments are appropriate and necessary.

Q: Can I appeal a prior authorization denial?
A: Yes, you have the right to appeal a denial. Your insurance company should provide information on the appeals process.

Q: What can I do if I’m experiencing problems with prior authorization?
A: Talk to your doctor’s office and your insurance company. You can also contact your state insurance regulator for assistance.

Q: Are there any legislative efforts to address prior authorization?
A: Yes, several states are considering legislation to streamline the prior authorization process and increase transparency.

Did you know? Nearly half of insured adults have experienced a healthcare service, treatment, or medication being either denied or delayed due to prior authorization in the past two years.

Pro Tip: Always check with your insurance company before starting a new treatment or medication to understand the prior authorization requirements.

What are your experiences with prior authorization? Share your thoughts in the comments below!

You may also like

Leave a Comment